High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer

The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC. Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohist...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 740120
Main Authors Wang, Mingliang, Lu, Yida, Wang, Huizhen, Wu, Youliang, Xu, Xin, Li, Yongxiang
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 17.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC. Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function . Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis. ATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (  < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells , while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells. These findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC.
AbstractList The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.BACKGROUNDThe role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function in vitro. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.METHODSExpression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function in vitro. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.ATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (p < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells in vitro, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.RESULTSATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (p < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells in vitro, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.These findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC.CONCLUSIONThese findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC.
The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC. Expression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function . Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis. ATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (  < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells , while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells. These findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC.
BackgroundThe role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the expression levels and biological functions of ATF4 in GC.MethodsExpression of ATF4 was detected by quantitative PCR (qPCR), Western blotting, and immunohistochemistry. Cox regression was used for survival analysis and the construction of the nomogram. Immunofluorescence was used to identify the intracellular localization of ATF4. Knockdown and overexpression of ATF4 in GC cells followed by wound healing and Transwell assays, EdU and Calcein-AM/propidium iodide (PI) staining, and cell cycle detection were performed to examine its function in vitro. Transmission electron microscopy was performed to assess the autophagy levels upon ATF4 silencing. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and gene set enrichment analysis (GSEA) were used to determine gene enrichment. SPSS 22.0 software, GraphPad Prism 7.0, and R version 3.6.1 were used for statistical analysis.ResultsATF4 expression was upregulated in GC cells and tissues compared with corresponding normal tissues. Survival analysis suggested that a high ATF4 expression was strongly associated with worse overall survival (OS) of GC patients (p < 0.001). The nomogram and the receiver operating characteristic (ROC) curves demonstrated that ATF4 was a highly sensitive and specific prognostic marker of GC [C-index = 0.797, area under the ROC curve (AUC) of 3-year OS = 0.855, and AUC of 5-year OS = 0.863]. In addition, ATF4 knockdown inhibited the cell proliferation, migration, invasion, and cell cycle progression of GC cells in vitro, while overexpression of ATF4 exerted the opposite effects. Bioinformatics analysis showed that ATF4 could promote GC progression possibly by regulating asparagine (Asn) metabolism and autophagy pathways. Further experiments indicated that ATF4 expression was significantly positively correlated with ASNS expression. The inhibition of cell clone formation in Asn-deprived conditions was more significant in the shATF4 group. Finally, we found that ATF4 promoted autophagy through regulating the mTORC1 pathway in GC cells.ConclusionThese findings suggested that ATF4 can significantly promote GC development and serve as an independent prognostic factor for GC.
Author Li, Yongxiang
Wu, Youliang
Wang, Mingliang
Xu, Xin
Wang, Huizhen
Lu, Yida
AuthorAffiliation General Surgery Department, The First Affiliated Hospital of Anhui Medical University , Hefei , China
AuthorAffiliation_xml – name: General Surgery Department, The First Affiliated Hospital of Anhui Medical University , Hefei , China
Author_xml – sequence: 1
  givenname: Mingliang
  surname: Wang
  fullname: Wang, Mingliang
– sequence: 2
  givenname: Yida
  surname: Lu
  fullname: Lu, Yida
– sequence: 3
  givenname: Huizhen
  surname: Wang
  fullname: Wang, Huizhen
– sequence: 4
  givenname: Youliang
  surname: Wu
  fullname: Wu, Youliang
– sequence: 5
  givenname: Xin
  surname: Xu
  fullname: Xu, Xin
– sequence: 6
  givenname: Yongxiang
  surname: Li
  fullname: Li, Yongxiang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34976799$$D View this record in MEDLINE/PubMed
BookMark eNp1kktvEzEUhS1UREvpnhXykkUT_BqP7wZpFPURqRVdFMHO8ng8E1cTO9hORf89E9JWLRLe2Lo-5zuLe96jgxCDQ-gjJXPOFXzpY7BzRhid14JQRt6gI8a4mIHgPw9evA_RSc53ZDqyIpTwd-iQC6hlDXCEwqUfVri5PRf47PcmuZx9DHiZcZNztN4U1-EfvqzwTYwJ36Q4hJh9PsXN2oeIG-s7fO2KaePo8_oUm9DhZlviZmWGB-wDvjC5JG_xwgTr0gf0tjdjdieP9zH6fn52u7icXX27WC6aq5kVkpVZy2jf8gqMUJJXDCrHhHDCCAO9MQAt4z3wjlPHVKcYIcxWFeuJ6l0PrbP8GC333C6aO71Jfm3Sg47G67-DmAZtUvF2dFp1jNasVsAqJVQvFQCtOEgCDgST1cT6umdttu3addaFksz4Cvr6J_iVHuK9VjVVEmACfH4EpPhr63LRa5-tG0cTXNxmzSSVTAkAMkk_vcx6Dnla2CSQe4FNMefkem19MWVa2hTtR02J3pVD78qhd-XQ-3JMRvKP8Yn9X8sfH4q7UA
CitedBy_id crossref_primary_10_1038_s41598_024_63895_y
crossref_primary_10_3390_metabo13050656
crossref_primary_10_1080_21655979_2022_2066759
crossref_primary_10_2174_0113894501328461240921062056
crossref_primary_10_1016_j_oor_2025_100735
crossref_primary_10_1158_2159_8290_CD_22_1230
crossref_primary_10_3390_ijms231810564
crossref_primary_10_1038_s41598_024_80027_8
crossref_primary_10_1016_j_bbcan_2023_189062
crossref_primary_10_1097_CEJ_0000000000000817
crossref_primary_10_1016_j_actbio_2024_05_033
crossref_primary_10_1111_febs_16992
crossref_primary_10_1186_s12935_024_03279_4
crossref_primary_10_3389_fonc_2023_1218989
crossref_primary_10_3390_cancers15051429
crossref_primary_10_3389_fnmol_2023_1112253
crossref_primary_10_3390_cimb46080519
crossref_primary_10_1016_j_phrs_2024_107355
crossref_primary_10_1016_j_cellsig_2024_111309
crossref_primary_10_1038_s41419_024_07049_y
crossref_primary_10_3390_cancers15092661
crossref_primary_10_1007_s12032_022_01879_6
crossref_primary_10_1038_s41417_023_00653_8
crossref_primary_10_1186_s10020_024_01062_9
crossref_primary_10_1016_j_jddst_2024_105998
crossref_primary_10_1016_j_molcel_2024_04_016
Cites_doi 10.1093/bioinformatics/bty271
10.1016/j.biopha.2019.109118
10.1080/15548627.2019.1606647
10.3390/cells8121510
10.1016/j.ccell.2017.12.003
10.3322/caac.21492
10.1093/nar/gkv1070
10.1016/j.celrep.2018.04.032
10.3748/wjg.v22.i8.2403
10.1111/jcmm.15736
10.3892/ijmm.2017.2985
10.1073/pnas.84.23.8355
10.1002/cbin.10760
10.3389/fendo.2020.00556
10.1016/j.jri.2020.103120
10.1172/JCI39366
10.1038/onc.2017.376
10.1158/1078-0432.CCR-17-3125
10.1016/j.molcel.2020.05.007
10.1042/EBC20170027
10.3390/ijms22115566
10.1245/s10434-010-0985-4
10.1172/JCI78031
10.1093/annonc/mdy502
10.1186/s12885-021-08143-6
10.1517/14728222.2012.728207
10.1016/j.cmet.2017.09.001
10.1038/s41418-020-00688-6
10.1038/s41556-019-0347-9
10.1001/jamaoncol.2018.0013
10.7554/eLife.63326
10.1016/j.lfs.2020.117277
10.1158/0008-5472.CAN-20-3694
10.3389/fcell.2020.00177
10.1080/15384101.2016.1151581
10.1016/S1470-2045(18)30739-3
10.1186/1476-4598-13-225
10.1093/jn/nxz309
10.1271/bbb.110990
10.1158/0008-5472
10.1210/jc.2016-2878
10.3389/fonc.2021.654940
10.7150/ijms.43167
10.1371/journal.pone.0031431
ContentType Journal Article
Copyright Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li.
Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li 2021 Wang, Lu, Wang, Wu, Xu and Li
Copyright_xml – notice: Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li.
– notice: Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li 2021 Wang, Lu, Wang, Wu, Xu and Li
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fonc.2021.740120
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
ExternalDocumentID oai_doaj_org_article_8d217278925848f68991539609e94265
PMC8718699
34976799
10_3389_fonc_2021_740120
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-b21fb359a48635295e244e4a4a9faa99b23f93d31e28d82002c552f08fef9bec3
IEDL.DBID M48
ISSN 2234-943X
IngestDate Wed Aug 27 01:31:05 EDT 2025
Thu Aug 21 18:31:54 EDT 2025
Fri Jul 11 08:10:12 EDT 2025
Thu Apr 03 06:52:37 EDT 2025
Tue Jul 01 02:46:15 EDT 2025
Thu Apr 24 23:09:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords metabolism
autophagy
nomogram
gastric cancer
ATF4
activating transcription factor 4
Language English
License Copyright © 2021 Wang, Lu, Wang, Wu, Xu and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-b21fb359a48635295e244e4a4a9faa99b23f93d31e28d82002c552f08fef9bec3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID: Yongxiang Li, orcid.org/0000-0001-7183-9485; Mingliang Wang, orcid.org/0000-0002-4830-9467
This article was submitted to Gastrointestinal Cancers: Gastric & Esophageal Cancers, a section of the journal Frontiers in Oncology
Reviewed by: Souvik Dey, Manipal Academy of Higher Education (MAHE), India; Dean Craig Singleton, The University of Auckland, New Zealand
Edited by: Yumin Li, Lanzhou University, China
OpenAccessLink https://doaj.org/article/8d217278925848f68991539609e94265
PMID 34976799
PQID 2616284990
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_8d217278925848f68991539609e94265
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8718699
proquest_miscellaneous_2616284990
pubmed_primary_34976799
crossref_citationtrail_10_3389_fonc_2021_740120
crossref_primary_10_3389_fonc_2021_740120
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-17
PublicationDateYYYYMMDD 2021-12-17
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-17
  day: 17
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in oncology
PublicationTitleAlternate Front Oncol
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Lee (B6) 1987; 84
Singleton (B17) 2012; 16
Powers (B26) 2018; 34
Sun (B27) 2020; 125
Zhang (B31) 2020; 24
Liu (B10) 2020; 139
Shitara (B3) 2018; 19
Muro (B2) 2019; 30
Gwinn (B41) 2018; 33
Du (B37) 2021; 18
Yoshizawa (B13) 2009; 119
Li (B8) 2017; 41
Horiguchi (B19) 2012; 72
Ligasová (B22) 2019; 8
Torrence (B15) 2021; 10
Alsterda (B34) 2021; 11
Wu (B40) 2017; 40
Tameire (B18) 2019; 21
Dey (B20) 2015; 125
Rabanal-Ruiz (B30) 2017; 61
Yang (B12) 2018; 23
Jiao (B28) 2020; 8
Yang (B42) 2020; 16
Fuchs (B4) 2018; 4
Bray (B1) 2018; 68
Sun (B23) 2014; 13
Wu (B24) 2021; 21
Martinez (B36) 2021; 81
González-González (B38) 2018; 24
Linares (B11) 2017; 26
Qu (B35) 2021; 22
He (B43) 2020; 79
Xu (B14) 2020; 150
Zhu (B44) 2012; 7
Edge (B21) 2010; 17
Bagheri-Yarmand (B39) 2017; 102
Demmings (B7) 2021; 28
Li (B32) 2020; 243
Ku (B9) 2020; 11
Tsuji-Naito (B29) 2012; 76
Kanehisa (B25) 2016; 44
Heydt (B16) 2018; 37
Qin (B33) 2016; 15
Digklia (B5) 2016; 22
References_xml – volume: 34
  start-page: I 555
  year: 2018
  ident: B26
  article-title: GSEA-InContext: Identifying Novel and Common Patterns in Expression Experiments
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty271
– volume: 125
  year: 2020
  ident: B27
  article-title: Magnoflorine Inhibits Human Gastric Cancer Progression by Inducing Autophagy, Apoptosis and Cell Cycle Arrest by JNK Activation Regulated by ROS
  publication-title: BioMed Pharmacother
  doi: 10.1016/j.biopha.2019.109118
– volume: 16
  year: 2020
  ident: B42
  article-title: MTORC1 Coordinates the Autophagy and Apoptosis Signaling in Articular Chondrocytes in Osteoarthritic Temporomandibular Joint
  publication-title: Autophagy
  doi: 10.1080/15548627.2019.1606647
– volume: 8
  start-page: 1510
  year: 2019
  ident: B22
  article-title: A New Sensitive Method for the Detection of Mycoplasmas Using Fluorescence Microscopy
  publication-title: Cells
  doi: 10.3390/cells8121510
– volume: 33
  start-page: 91
  year: 2018
  ident: B41
  article-title: Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.12.003
– volume: 68
  start-page: 394
  year: 2018
  ident: B1
  article-title: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21492
– volume: 44
  year: 2016
  ident: B25
  article-title: KEGG as a Reference Resource for Gene and Protein Annotation
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkv1070
– volume: 23
  year: 2018
  ident: B12
  article-title: ATF4 Regulates CD4+ T Cell Immune Responses Through Metabolic Reprogramming
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2018.04.032
– volume: 22
  year: 2016
  ident: B5
  article-title: Advanced Gastric Cancer: Current Treatment Landscape and Future Perspectives
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i8.2403
– volume: 24
  year: 2020
  ident: B31
  article-title: M6a Methyltransferase METTL3 Promotes Retinoblastoma Progression via PI3K/AKT/mTOR Pathway
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.15736
– volume: 40
  year: 2017
  ident: B40
  article-title: Silencing of Both ATF4 and PERK Inhibits Cell Cycle Progression and Promotes the Apoptosis of Differentiating Chondrocytes
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2017.2985
– volume: 84
  year: 1987
  ident: B6
  article-title: A Cellular Protein, Activating Transcription Factor, Activates Transcription of Multiple E1A-Inducible Adenovirus Early Promoters
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.84.23.8355
– volume: 41
  start-page: 599
  year: 2017
  ident: B8
  article-title: Silencing of ATF2 Inhibits Growth of Pancreatic Cancer Cells and Enhances Sensitivity to Chemotherapy
  publication-title: Cell Biol Int
  doi: 10.1002/cbin.10760
– volume: 11
  year: 2020
  ident: B9
  article-title: Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2020.00556
– volume: 139
  year: 2020
  ident: B10
  article-title: Activating Transcription Factor 6 Regulated Cell Growth, Migration and Inhibiteds Cell Apoptosis and Autophagy via MAPK Pathway in Cervical Cancer
  publication-title: J Reprod Immunol
  doi: 10.1016/j.jri.2020.103120
– volume: 119
  year: 2009
  ident: B13
  article-title: The Transcription Factor ATF4 Regulates Glucose Metabolism in Mice Through Its Expression in Osteoblasts
  publication-title: J Clin Invest
  doi: 10.1172/JCI39366
– volume: 37
  year: 2018
  ident: B16
  article-title: Oncogenic FLT3-ITD Supports Autophagy via ATF4 in Acute Myeloid Leukemia
  publication-title: Oncogene
  doi: 10.1038/onc.2017.376
– volume: 24
  year: 2018
  ident: B38
  article-title: Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-3125
– volume: 79
  start-page: 30
  year: 2020
  ident: B43
  article-title: Acetyl-CoA Derived From Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2020.05.007
– volume: 61
  year: 2017
  ident: B30
  article-title: mTORC1 as the Main Gateway to Autophagy
  publication-title: Essays Biochem
  doi: 10.1042/EBC20170027
– volume: 22
  year: 2021
  ident: B35
  article-title: Autophagy Induction by Trichodermic Acid Attenuates Endoplasmic Reticulum Stress-Mediated Apoptosis in Colon Cancer Cells
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22115566
– volume: 17
  year: 2010
  ident: B21
  article-title: The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-010-0985-4
– volume: 125
  year: 2015
  ident: B20
  article-title: ATF4-Dependent Induction of Heme Oxygenase 1 Prevents Anoikis and Promotes Metastasis
  publication-title: J Clin Invest
  doi: 10.1172/JCI78031
– volume: 30
  start-page: 19
  year: 2019
  ident: B2
  article-title: Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients With Metastatic Gastric Cancer: A JSMO-ESMO Initiative Endorsed by CSCO, KSMO, MOS, SSO and TOS
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdy502
– volume: 21
  start-page: 433
  year: 2021
  ident: B24
  article-title: Expression and Functional Characterization of INPP4B in Gallbladder Cancer Patients and Gallbladder Cancer Cells
  publication-title: BMC Cancer
  doi: 10.1186/s12885-021-08143-6
– volume: 16
  year: 2012
  ident: B17
  article-title: Targeting the ATF4 Pathway in Cancer Therapy
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.2012.728207
– volume: 26
  start-page: 817
  year: 2017
  ident: B11
  article-title: ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the P62-Deficient Tumor Stroma
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.09.001
– volume: 28
  year: 2021
  ident: B7
  article-title: Activating Transcription Factor-4 Promotes Neuronal Death Induced by Parkinson's Disease Neurotoxins and α-Synuclein Aggregates
  publication-title: Cell Death Differ
  doi: 10.1038/s41418-020-00688-6
– volume: 21
  year: 2019
  ident: B18
  article-title: ATF4 Couples MYC-Dependent Translational Activity to Bioenergetic Demands During Tumour Progression
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-019-0347-9
– volume: 4
  start-page: e180013
  year: 2018
  ident: B4
  article-title: Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2018.0013
– volume: 10
  start-page: e63326
  year: 2021
  ident: B15
  article-title: The mTORC1-Mediated Activation of ATF4 Promotes Protein and Glutathione Synthesis Downstream of Growth Signals
  publication-title: Elife
  doi: 10.7554/eLife.63326
– volume: 243
  year: 2020
  ident: B32
  article-title: Berberine Mitigates High Glucose-Induced Podocyte Apoptosis by Modulating Autophagy via the mTOR/P70S6K/4EBP1 Pathway
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.117277
– volume: 81
  year: 2021
  ident: B36
  article-title: SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-3694
– volume: 8
  year: 2020
  ident: B28
  article-title: Adipose-Derived Stem Cells Protect Ischemia-Reperfusion and Partial Hepatectomy by Attenuating Endoplasmic Reticulum Stress
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2020.00177
– volume: 15
  year: 2016
  ident: B33
  article-title: 4e-BP1, A Multifactor Regulated Multifunctional Protein
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2016.1151581
– volume: 19
  year: 2018
  ident: B3
  article-title: Trifluridine/tipiracil Versus Placebo in Patients With Heavily Pretreated Metastatic Gastric Cancer (TAGS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(18)30739-3
– volume: 13
  year: 2014
  ident: B23
  article-title: Down Regulation of Thrombospondin2 Predicts Poor Prognosis in Patients With Gastric Cancer
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-13-225
– volume: 150
  year: 2020
  ident: B14
  article-title: ATF4-Mediated Upregulation of REDD1 and Sestrin2 Suppresses mTORC1 Activity During Prolonged Leucine Deprivation
  publication-title: J Nutr
  doi: 10.1093/jn/nxz309
– volume: 76
  year: 2012
  ident: B29
  article-title: Concentrated Bovine Milk Whey Active Proteins Facilitate Osteogenesis Through Activation of the JNK-ATF4 Pathway
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.110990
– volume: 72
  start-page: 395
  year: 2012
  ident: B19
  article-title: Stress-Regulated Transcription Factor ATF4 Promotes Neoplastic Transformation by Suppressing Expression of the INK4a/ARF Cell Senescence Factors
  publication-title: Cancer Res
  doi: 10.1158/0008-5472
– volume: 102
  year: 2017
  ident: B39
  article-title: ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-2878
– volume: 11
  year: 2021
  ident: B34
  article-title: Salubrinal Exposes Anticancer Properties in Inflammatory Breast Cancer Cells by Manipulating the Endoplasmic Reticulum Stress Pathway
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.654940
– volume: 18
  year: 2021
  ident: B37
  article-title: ATF4 Promotes Lung Cancer Cell Proliferation and Invasion Partially Through Regulating Wnt/β-Catenin Signaling
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.43167
– volume: 7
  start-page: e31431
  year: 2012
  ident: B44
  article-title: Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells Through Transactivation of SIRT1 Expression
  publication-title: PloS One
  doi: 10.1371/journal.pone.0031431
SSID ssj0000650103
Score 2.416794
Snippet The role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the...
BackgroundThe role of activating transcription factor 4 (ATF4) underlying gastric cancer (GC) remains unclear. The purpose of this study was to investigate the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 740120
SubjectTerms activating transcription factor 4
ATF4
autophagy
gastric cancer
metabolism
nomogram
Oncology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhh5JLaZu0ddIUFXIJxN2sLcnS0Q3ZpIUNOSQ0NyHr0RgSOex6of33mbG9y24p7aVXP7CYh78ZZvg-Qo5yYQRAgYVM4zxlwsvUCFukgfuqUtk4VA4nutMrcXnLvt3xuzWpL9wJ6-mBe8ONpEMJpUKqDKBSBgH9ASQp8qR5BejSsZcC5q01U_0_mKOAQT-XhC5MjUITkbEwG39GDTqU917DoY6u_0815u-rkmvYM3lFXg5FIy37w74mWz6-IS-mw1h8l0Tc1qDlzYTR85_DZmukX-d0aXzv6Pe6vafXTTOj17MGt-vq-QktH-vY0NLWjk59C_HwUM8fT6iJjpYLpBwwP37ROtILg_Ielp5hjMz2yO3k_ObsMh2EFFLLRNamFdo858owCfVFprgHUPfMMKOCMUpVWR5U7vKxz6STuLZhOc_CqQw-KHBy_pZsxyb694Qi5ZQ3ooDMtcxV0JcLw5wNIfenzAuekNHSrNoOLOModvGgodtAR2h0hEZH6N4RCTlevfHUM2z85dkv6KnVc8iN3V2AiNFDxOh_RUxCPi39rCGXcEBiom8Wcw3dpAC4BoBOyLve76tP5QwKt0KphBQbEbFxls07sb7v-LqhJ5VCqf3_cfgDsoP2wIWacfGBbLezhT-EsqitPnYZ8AxOUAaI
  priority: 102
  providerName: Directory of Open Access Journals
Title High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/34976799
https://www.proquest.com/docview/2616284990
https://pubmed.ncbi.nlm.nih.gov/PMC8718699
https://doaj.org/article/8d217278925848f68991539609e94265
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBYlhdJLadPXJm1QoZdCnMR62TqE4IZs0sKWHLJ0b0a2pcSwkRvbC8m_74zt3WbLUnrxwZYtWd-MZsYaf0PIZ66MAlOQg6ZJGQhl48CoPAqctFmmWeiyAnd0Jz_UxVR8n8nZn9-jhwlsNoZ2WE9qWs8P7u8eTkDhjzHiBHt76CqPZIQsPMDycgwC-KdglyJU08ng7PfrssSiBlhtjnERaMFn_b7lxoes2amOzn-TD_p3KuUj2zR-SV4MTiVNeil4RZ5Yv02eTYZt89fEYzYHTa7Ggp7dD5mvnn5r6BIcW9CfZXtDL6uqppd1hdl3ZbNPk9vSVzTJy4JObAvyMi-b231qfEGTBVISmOsHWnp6brD8R05PUYbqN2Q6Prs6vQiGQgtBLhRrgwwx4VIbEYP_wbS0YPStMMJoZ4zWGeNO84KHlsVFjGkduZTMHcXOOg1CwN-SLV95-55QpKSyRkWg2bkoMojblRFF7hy3R8IqOSKHy2lN84GFHIthzFOIRhCIFIFIEYi0B2JEvqzu-NUzcPyj7VdEatUOubO7E1V9nQ6qmMYFFuWKYs3A-YqdgogTln1k3rMa_BUY4qclzinoGm6gGG-rRZNCtKnAnIMBH5F3Pe6rrrgAxy7SekSiNYlYG8v6FV_edHzeELPGSuud_-h3lzzH18V8mjD6QLbaemE_glfUZnvd1wQ4ns_CvU7wfwOZcQpE
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+ATF4+Expression+Is+Associated+With+Poor+Prognosis%2C+Amino+Acid+Metabolism%2C+and+Autophagy+in+Gastric+Cancer&rft.jtitle=Frontiers+in+oncology&rft.au=Wang%2C+Mingliang&rft.au=Lu%2C+Yida&rft.au=Wang%2C+Huizhen&rft.au=Wu%2C+Youliang&rft.date=2021-12-17&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=11&rft.spage=740120&rft_id=info:doi/10.3389%2Ffonc.2021.740120&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon